Jie Wang

Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multi-Omics Data Analysis

The paper develops a prognostic model and drug selection framework for clear cell renal cell carcinoma using multi-omics data from TCGA, identifying high- and low-risk patient subtypes with significant survival differences.

Establishment of a prognosis prediction model based on pyroptosis-related signatures associated with the immune microenvironment and molecular heterogeneity in clear cell renal carcinoma

The paper identifies two pyroptosis subtypes in ccRCC and constructs a prognosis prediction model based on pyroptosis-related risk scores.